1
|
Nara H, Kaieda A, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M. Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach. J Med Chem 2017; 60:608-626. [DOI: 10.1021/acs.jmedchem.6b01007] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Affiliation(s)
- Hiroshi Nara
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Akira Kaieda
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Kenjiro Sato
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Takako Naito
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Hideyuki Mototani
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Hideyuki Oki
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Yoshio Yamamoto
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Haruhiko Kuno
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Takashi Santou
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Naoyuki Kanzaki
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Jun Terauchi
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Osamu Uchikawa
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| | - Masakuni Kori
- Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan
| |
Collapse
|
3
|
Smith TE, Kuo WH, Balskus EP, Bock VD, Roizen JL, Theberge AB, Carroll KA, Kurihara T, Wessler JD. Total Synthesis of (−)-Hennoxazole A. J Org Chem 2007; 73:142-50. [DOI: 10.1021/jo7018015] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Thomas E. Smith
- Department of Chemistry, Williams College, Williamstown, Massachusetts 01267
| | - Wen-Hsin Kuo
- Department of Chemistry, Williams College, Williamstown, Massachusetts 01267
| | - Emily P. Balskus
- Department of Chemistry, Williams College, Williamstown, Massachusetts 01267
| | - Victoria D. Bock
- Department of Chemistry, Williams College, Williamstown, Massachusetts 01267
| | - Jennifer L. Roizen
- Department of Chemistry, Williams College, Williamstown, Massachusetts 01267
| | | | - Kathleen A. Carroll
- Department of Chemistry, Williams College, Williamstown, Massachusetts 01267
| | - Tomoki Kurihara
- Department of Chemistry, Williams College, Williamstown, Massachusetts 01267
| | - Jeffrey D. Wessler
- Department of Chemistry, Williams College, Williamstown, Massachusetts 01267
| |
Collapse
|
4
|
Zou Y, Fahmi NE, Vialas C, Miller GM, Hecht SM. Total synthesis of deamido bleomycin a(2), the major catabolite of the antitumor agent bleomycin. J Am Chem Soc 2002; 124:9476-88. [PMID: 12167044 DOI: 10.1021/ja012741l] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Metabolic inactivation of the antitumor antibiotic bleomycin is believed to be mediated exclusively via the action of bleomycin hydrolase, a cysteine proteinase that is widely distributed in nature. While the spectrum of antitumor activity exhibited by the bleomycins is believed to reflect the anatomical distribution of bleomycin hydrolase within the host, little has been done to characterize the product of the putative inactivation at a chemical or biochemical level. The present report describes the synthesis of deamidobleomycin demethyl A(2) (3) and deamido bleomycin A(2) (4), as well as the respective aglycones. These compounds were all accessible via the key intermediate N(alpha)-Boc-N(beta)-[1-amino-3(S)-(4-amino-6-carboxy-5-methylpyrimidin-2-yl)propion-3-yl]-(S)-beta-aminoalanine tert-butyl ester (16). Synthetic deamido bleomycin A(2) was shown to be identical to the product formed by treatment of bleomycin A(2) with human bleomycin hydrolase, as judged by reversed-phase HPLC analysis and (1)H NMR spectroscopy. Deamido bleomycin A(2) was found to retain significant DNA cleavage activity in DNA plasmid relaxation assays and had the same sequence selectivity of DNA cleavage as bleomycin A(2). The most significant alteration of function noted in this study was a reduction in the ability of deamido bleomycin A(2) to mediate double-strand DNA cleavage, relative to that produced by BLM A(2).
Collapse
Affiliation(s)
- Ying Zou
- Contribution from the Department of Chemistry, University of Virginia, Charlottesville 22901, USA
| | | | | | | | | |
Collapse
|
6
|
Evans DA, Fitch DM, Smith TE, Cee VJ. Application of Complex Aldol Reactions to the Total Synthesis of Phorboxazole B. J Am Chem Soc 2000. [DOI: 10.1021/ja002356g] [Citation(s) in RCA: 164] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- David A. Evans
- Contribution from the Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138
| | - Duke M. Fitch
- Contribution from the Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138
| | - Thomas E. Smith
- Contribution from the Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138
| | - Victor J. Cee
- Contribution from the Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138
| |
Collapse
|
7
|
Garey D, Ramirez Ml ML, Gonzales S, Wertsching A, Tith S, Keefe K, Peña MR. An Approach to Substituted 4-Hydroxypyran-2-ones: The Total Synthesis of Phenoxan. J Org Chem 1996; 61:4853-4856. [PMID: 11667430 DOI: 10.1021/jo960221g] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Donna Garey
- Department of Chemistry and Biochemistry, Arizona State University, Box 871604, Tempe, Arizona 85287-1604
| | | | | | | | | | | | | |
Collapse
|
9
|
Mikhaleva MA, Kolesnichenko GA, Rubina KI, Gol'dberg YS, Savel'ev VA, Leitis LY, Shimanskaya MV, Mamaev VP. Synthesis of 5-arylpyrimidine-2-carboxylic acids and the liquid-crystal characteristics of their aryl esters. Chem Heterocycl Compd (N Y) 1986. [DOI: 10.1007/bf00515002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|